Press & News

People are different and so is their cancer, patients should be treated individually.

2cureX tumoroid technology shown to recapitulate tumor heterogeneity

February 1, 2018


A collaborative project between the Department of Molecular Medicine, Aarhus University Hospital, Denmark and 2cureX has recently been published in the peer reviewed journal Molecular Oncology (PubMed link). The study demonstrates that the 2cureX tumoroid technology recapitulates the general genetic inter and intratumor heterogeneity found in colorectal cancer. This was shown using multiple samples within tumours from several patients.

 It is important for IndiTreat™ that our tumoroids mimic the originating tumor as closely as possible. The results from this exciting collaboration clearly show that our tumoroid technology can replicate the complex genetic markup of a tumor.” says Jacob Thastrup, Head of Research, 2cureX.